This transmittal provides notice of coverage and reimbursement for Monoclonal Antibody infusions in the professional fee schedule for fee-for-service providers that bill HCPCS and CPT codes on CMS-1500 claim forms, and for providers enrolled in Medicaid Managed Care Organization (MCO) networks.

This transmittal amends guidance provided in Transmittal #22-18 (rev.) COVID-19 Monoclonal Antibody Infusions Update issued May 9, 2022. This revision reflects updated coverage and pricing for the product Bebtelovimab 175 which has transitioned away from being provided by the U.S. government freely to the private market for purchase.